Author
GlaxoSmithKline (Germany)ORCID 0000-0003-0575-6766Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Rachel E. Heap, David W. Frederick, Robert J. Pickering…·Lee M. Booty
This study identifies NLRX1 as a druggable, CypD-independent regulator of mitochondrial permeability transition using chemical probes and genetic approaches.
Celia Alda-Catalinas, Ximena Ibarra-Soria, Christina Flouri…·Radu Rapiteanu
The paper develops a CRISPRi-based single-cell screening approach to map non-coding regulatory elements to genes in primary human CD4+ T cells and demonstrates its utility for GWAS effector gene identification.
Benedikt Rauscher, William F. Mueller, Sandra Clauder‐Münster…·Lars Michael Steinmetz
The paper characterizes gene and protein expression changes in NGLY1 deficiency using patient-derived cells and provides a web resource for the data.